Lenzing Shares Slide as €300 Million Rights Issue Dilutes Existing Holders
Published on 10/08/2026 at 13:10 | Editorial boerse-global.de
Lenzing's equity came under renewed pressure on Thursday, with the fibre producer's shares retreating 8.6% to €11.52 as fresh disclosures tied to its ongoing capital raise filtered through the market. The decline extended a bruising stretch for the stock, which has now shed 19.5% since the cash call was set in motion roughly a week ago.
The scale of the dilution is the central issue. Lenzing is issuing 34,756,362 new no-par shares at a subscription price of €8.65 apiece, a level that represents a 42.50% theoretical discount to the ex-rights price. The subscription ratio stands at ten to nine. Existing shares have traded ex-rights on the Vienna Stock Exchange since 2 October.
That combination — a deep discount and a large share count increase — is weighing heavily on sentiment. Shareholders who decline to exercise their subscription rights face a marked erosion of their proportional stake, and the arithmetic has kept sellers active on the Wiener Börse. The fully underwritten transaction is targeting gross proceeds of around €300 million, with the fresh capital flowing directly to the company.
Board Member and Oberbank Take Up Rights
Thursday's regulatory filings offered a window into how the rights are being absorbed. Christian Skilich, a member of Lenzing's management board, was allotted 1,710 subscription rights, with Tuesday recorded as the execution date. The Oberbank AG booked a far larger package of 1,493,524 rights on the same day, according to a separate disclosure.
Should investors sell immediately? Or is it worth buying Lenzing?
Those allocations sit within the framework of the support commitments underpinning the capital measure. Alongside Oberbank, the B&C Group and major shareholder Suzano are acting as guarantors of the transaction. Handelsblatt reported on Tuesday that analysts had voiced scepticism about Suzano expanding its Lenzing investment.
Berenberg Cuts to Hold, Slashes Target
The most pointed analyst revision arrived on 2 October, when Berenberg downgraded the stock from "Buy" to "Hold" and cut its price target sharply from €29.50 to €17.00. The bank pointed to persistent cost inflation and restructuring provisions linked to plant closures. It also flagged the impending capital increase, noting that higher cotton and viscose prices had failed to feed through to operating results as anticipated. Analysts at Raiffeisen, according to media reports, identified the sheer extent of the dilution as a key driver of the selling pressure.
Rights Trading Runs to 14 October
The subscription period has been open since Tuesday and closes for investors on 20 October. Trading in the subscription rights on the Vienna Stock Exchange is scheduled to run through 14 October. Any shares left unsubscribed once the period ends are to be placed through an international private placement, a step designed to ensure the transaction is fully placed.
Lenzing at a turning point? This analysis reveals what investors need to know now.
Settlement and delivery of the new shares is expected on 23 October, subject to entry in the commercial register. Lenzing will report third-quarter 2026 results on 5 November.
With the subscription window still open, the terms of the new issue and the shifting positions of major market participants look set to remain the dominant force steering the share price.
Ad
Lenzing Stock: New Analysis - 8 October
Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
